Skip to content

Author

Ohoud A. Almadani

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation

Thrombotic and bleeding events were common in this real-world cohort of patients with cancer and AF receiving apixaban, highlighting the complexity of anticoagulation management in this high-risk population and support the need for close clinical monitoring and further prospective studies.

Lolwa Alabdelmuhsin, Metab F. Alwethairi, D. Alharbi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.